In Brief This Week: Roche; Hologic; Agilent Technologies; Charles River Laboratories; Gentronix; Bruker, Netzsch; RayBiotech; Hendrix Genetics | GenomeWeb

NEW YORK (GenomeWeb News) – Presenting at an investors meeting in London this week, Roche said this week that is has more than 200 companion diagnostic projects ongoing across its pharma and diagnostics units. "More than 60 percent of our pharmaceutical pipeline projects are couples with the development of companion diagnostics in order to make treatments more effective," Roche CEO Severin Schwan said.

The firm also noted that approximately 50 percent of its R&D budget is allocated to oncology drugs and diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.